eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hypertriglyceridemia |
| Comorbidity | C0011849|diabetes mellitus |
| Sentences | 7 |
| PubMedID- 21510110 | Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. |
| PubMedID- 23853615 | Raised tg levels, small low density lipoprotein-cholesterol (ldl-c) particles, and low hdl-c (22)); low hdl-c was a component of mets only in the presence of hypertriglyceridemia in patients with type 2 diabetes mellitus (10). |
| PubMedID- 25573251 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridaemia in patients with type 2 diabetes mellitus20. |
| PubMedID- 23734746 | Background: postprandial hypertriglyceridemia in diabetes mellitus can be followed by endothelial dysfunction, impaired vascular compliance and increased cardiovascular complications. |
| PubMedID- 25617537 | This literature review discusses the safety on glucose metabolism of n-3 pufa supplementation in the treatment of hypertriglyceridemia in subjects with type 2 diabetes mellitus. |
| PubMedID- 24876549 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridemia in patients with type 2 diabetes mellitus. |
| PubMedID- 25035662 | Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus. |
Page: 1